Table 1. Changes in body weight during in vivo study

Groups Week 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 Week 11 Week 12 Week 13
Control (G1)1) 19.81±0.373) 20.50±0.33 21.93±0.52 22.50±0.62 23.84±0.49 23.83±0.492)*** 25.6±0.72*** 26.50±0.67*** 27.44±0.65*** 28.22±0.67*** 29.31±1.01*** 30.82±1.14*** 32.15±1.17*** 33.48±1.15***
HFD (G2) 19.82±0.24 20.53±0.35 23.72±0.35*** 25.79±0.27*** 27.75±0.31*** 27.95±0.84 30.5±0.60 32.82±0.74 34.67±0.85 36.09±0.93 37.52±1.14 39.48±1.23 40.43±1.11 41.36±1.08
Orlistat (10 mg/kg, G3) 19.81±0.33 20.94±0.40 24.23±0.50*** 25.96±0.58*** 27.65±0.73*** 27.92±0.58 29.8±0.35 31.5±0.68** 31.2±0.76*** 30.82±1.14*** 29.13±1.05*** 28.43±1.08*** 28.02±1.15*** 27.45±1.15***
Policosanol (5 mg/kg, G4) 19.82±0.27 20.85±0.40 23.85±0.22*** 25.93±0.37*** 27.97±0.45*** 27.91±0.48 30.1±0.80 32.0±0.49 33.7±0.71 35.14±0.46 36.37±1.08 38.32±0.69 37.61±0.75*** 36.81±0.83***
Policosanol (10 mg/kg, G5) 19.92±0.31 21.02±0.37* 24.18±0.54*** 26.04±0.46*** 28.23±0.60*** 27.95±0.48 30.7±0.42 32.1±0.46 33.6±0.48 35.05±0.53 36.82±0.73 37.51±0.79** 36.65±0.80*** 35.52±0.73***
Policosanol (20 mg/kg, G6) 19.92±0.27 21.05±0.43* 24.21±0.24*** 26.32±0.50*** 28.30±0.3*** 27.98±0.49 30.4±0.60 32.2±0.97 33.6±1.32 35.13±0.50 35.14±0.80*** 34.32±0.40*** 33.03±0.39*** 31.92±0.43***
Group 1 (G1), normal control group; Group 2 (G2), HFD-induced group; Group 3 (G3), treated orlistat drug (10 mg/kg) in HFD-induced group; Group 4 (G4), treated policosanol (5 mg/kg) in HFD-induced group; Group 5 (G5), treated policosanol (10 mg/kg) in HFD-induced group; Group 6 (G6), treated policosanol (20 mg/kg) in HFD-induced group.
Gray color means treatment of policosanol and orlistat period time in mice model.
All values are mean±SD (n=8).
p<0.05,
p<0.01, and
p<0.001 vs. Pathological control (HFD, G2).